Amedisys — Q4 2021 Earnings Presentation
20 slides from Amedisys's earnings presentation, Feb 23, 2022
Slide 1: Amedisys Fourth Quarter 2021 Earnings Call Supplemental Slides
Exhibit 99.2 Amedisys Fourth Quarter 2021 Earnings Call Supplemental Slides 1 1 th, February 24 2022
Slide 2: Forward-looking statements
Forward-looking statements This presentation may include forward-looking statements as defined by the Private www.amedisys.com Securities Litigation Reform Act of 1995. These forward-looking statements are based upon current expectations and assumptions about our business that are subject to a NASDA
Slide 3: A Look Back: FY 2021 Accomplishments
A Look Back FY 2021 Accomplishments Operational Excellence and Driving Growth Employer of Choice Clinical Distinction Efficiency• Grew Home Health same • Ended the year with overall • Maintained at least 95% of store total admissions • Grew EBITDA by 10% from voluntary turnover of all Home Health ca
Slide 4: Our Key Areas of Focus
Our Key Areas of Focus Strategic areas of focus and progress made during Q4’21 2 5 3 4 6 1 Recruiting / Clinical Organic Capacity and Regulatory M&A Retention Initiatives Growth Productivity • Signed a new • Home Health*: • Targeting industry • Quality: Amedisys • Focusing on 2021 Hospital at Home T
Slide 5: Highlights and Summary Financial Results (Adjusted): 4Q 2021
(1) Highlights and Summary Financial Results (Adjusted): 4Q 2021 Home Health total same store volume +2%, total same store admissions +2%; Hospice same store admissions -1%; Margin pressure driven by Hospice ADC decline & labor costs Adjusted Financial Results Amedisys Amedisys Amedisys Consolidated
Slide 6: Our Revenue Sources: 4Q'21
Our Revenue Sources: 4Q’21 Amedisys Consolidated Revenue Home Health Revenue Hospice Revenue 0.4% 5.3% 2.7% 19.1% 36.6% 12.7% 68.2% 60.3% 94.7% Home Health Hospice Medicare FFS Private Episodic Per Visit Medicare FFS Private Personal Care High Acuity Care • Home Health: 331 care centers; 34 states &
Slide 7: Home Health and Hospice Segment (Adjusted) – 4Q 2021
(1) Home Health and Hospice Segment (Adjusted) – 4Q 2021 Home Health total volume growth +2%; Hospice Admit Growth -1% HOSPICE HOME HEALTH Year Ended Year Ended $ in Millions 4Q20 4Q21 2020 2021 $ in Millions 4Q20 4Q21 2020 2021 Medicare 193.5 193.9 710.0 743.6 Medicare 228.3 230.1 847.3 914.5 Non-M
Slide 8: General & Administrative Expenses – Adjusted
(1,2) General & Administrative Expenses – Adjusted Impacted by COVID-19, acquisitions and investments to drive volume growth 4Q20 1Q21 2Q21 3Q21 4Q21 $ in Millions 4Q20 1Q21 2Q21 3Q21 4Q21 Salary and Benefits 25.0 23.4 22.0 22.1 21.7 Home Health Segment - Total 80.5 80.0 81.3 82.4 84.7 Other 13.2 12
Slide 9: Operational Excellence: Home Health Cost Per Visit (CPV)-Adjusted
Operational Excellence: Home Health Cost Per Visit (CPV)-Adjusted YOY Total CPV impacted by planned wage increases, wage inflation, new hire pay and higher health insurance costs. Contractor costs down slightly year over year as utilization has stabilized Components 4Q’20 3Q’21 4Q’21 YoY Variance De
Slide 10: Driving Top Line Growth
Driving Top Line Growth Home Health total volume, Hospice admissions and ADC, as well as Personal Care billable hours lagging due to prolonged COVID-19 impacts related to the Omicron variant (staffing challenges, increase in clinician quarantine and increase in hospice discharge rate) Home Health Ho
Slide 11: Industry Leading Quality Scores
Industry Leading Quality Scores Quality of Patient Care (QPC) Patient Satisfaction (PS) JAN 20 APR 20 OCT 20 JAN 22 JAN 20 APR 20 OCT 20 JAN 20 Metric Metric Release Release Release Release Release Release Release Release Quality of Patient 4.27 4.26 4.33 3.71 3.79 4.28 4.33 3.60 Patient Care Satisf
Slide 12: Hospice Quality: Moving Towards Best-in-Class
Hospice Quality: Amedisys Hospice Continues to Move Towards Best-in-Class Hospice Quality Notes: Included in the above analysis are active care centers. Acquired locations were only included if their acquisition date was before the start of the reporting window. Above excludes Asana, Aseracare, and
Slide 13: Debt and Liquidity Metrics
Debt and Liquidity Metrics Net leverage ~1.3x As of: Outstanding Debt 12/31/21 Outstanding Revolver - Outstanding Term Loan 447.2 Promissory Notes 0.8 Finance Leases 1.6 Total Debt Outstanding 449.6 Less: Deferred Debt Issuance Costs (4.5) Total Debt - Balance Sheet 445.1 Total Debt Outstanding 449.
Slide 14: Cash Flow Statement Highlights
(1) Cash Flow Statement Highlights 2020 includes benefit of payroll tax deferral (COVID-19 relief). Total payroll tax deferral of ~$55M (half paid in December 2021; remainder due in December 2022). $ in Millions 4Q20 1Q21 2Q21 3Q21 4Q21 GAAP Net Income 45.6 5 0.3 80.6 4 5.2 34.0 Changes in working c
Slide 15: Income Statement Adjustments
(1) Income Statement Adjustments $000s Income Statement Line Item 4Q20 1Q21 2Q21 3Q21 4Q21 Revenue Contingency accrual Net Serv ice Rev enue $ - $ - $ (6,541 ) $ - $ - Other Operating Income CARES Act & State COVID-1 9 grants Other Operating Income ( 6,7 80) (8,7 01 ) (4,603) 4 - Cost of Service COV
Slide 16: 2022 Guidance
2022 Guidance 16
Slide 17: Amedisys 2022 Preliminary Guidance
Amedisys 2022 Preliminary Guidance Revenue, EBITDA and EPS guidance ranges for FY 2022 ($M except for EPS) AMED Core High Acuity Care Total Performance AMED Adjusted Revenue $2,274 - $2,309 $56 $2,330 - $2,365 Adjusted $301 - $311 ($26) $275 - $285 EBITDA Adjusted EPS $5.88 - $6.10 ($0.65) $5.23 - $
Slide 18: 2022 Guidance Considerations
2022 Guidance Considerations EBITDA impacted by continued Hospice length of stay pressures, incremental Contessa investments, incentive compensation and costs related to Omicron Amedisys Home Health Hospice Personal Care Consolidated • Tax rate ~27% • Total same store • Total same store • Total bill
Slide 19: Environmental, Social, Governance (E.S.G.) Considerations
Environmental, Social, Governance (E.S.G.) Considerations 19
Slide 20: Environmental, Social, Governance (E.S.G.) Considerations
Environmental, Social, Governance (E.S.G.) Considerations Sustainable, high-quality, patient focused, home-based care model Environmental Social Governance • Amedisys strives to create an • Amedisys has a culture of compliance • Amedisys is dedicated to the organizational culture and climate in whic